Arkolith/Insider Trading/LEXX/Form 4

Turkel Catherine C.

DirectorLexaria Bioscience Corp. (LEXX) · full profile →Form 4 · filed Feb 27, 2023
Net Buying
Open-Market Buys
$4K
Open-Market Sells
$0
Net Open-Market Flow
$4K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 9, 2023Buy(P)2K$2.84$4K2K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001855763-23-000001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML